In addition, T-helper type 1 (TH1) gene expression, CTLA4 expression and the absence of fractalkine (CX3CL1) in baseline tumor specimens were also related with the response to the anti-PD-L1 antibody MPDL3280A in cancer patients [94]. The gene discussed is CX3CL1; the disease is neoplasm.